Pillstats
Rx only · Solution/ Drops · Ophthalmic

Dorzolamide Hydrochloride

Dorzolamide Hydrochloride

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)60207
US makers6 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.267$0.534$0.801$1.07Dec 2025Apr 2026Jul 2026
$0.821
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
6
Active US suppliers
43%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.6K7.1K11K14K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.9K
Rx · 2026 Q1
107K
Units dispensed
+22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown2SUPPLYING
Sandoz Incunknown1SUPPLYING
Micro Labs Limitedunknown1SUPPLYING
Sagent Pharmaceuticalsunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
Somerset Therapeutics, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.